{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:12:49Z","timestamp":1777443169174,"version":"3.51.4"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Measles is a highly contagious infectious disease. Maintaining a high level of measles immunity in the population is essential due to the extremely high transmissibility of the measles virus (MV). We analyzed the MV seroprevalence in the Croatian population. Methods: A total of 1998 individuals tested consecutively for MV antibodies from 2015 to 2025 inclusive were included. MV IgG antibodies were detected using a commercial ELISA. Results: The overall seroprevalence rate was 75.1%, with significant yearly differences, ranging from 50.0 to 86.5%, and a declining trend since 2023. No differences were observed between sexes (males 71.6%, females 71.9%). The seroprevalence increased with age, from 60.9% in the 1\u201310 age group to 91.1% in the 61+ age group. Significant geographic differences were found, with higher seropositivity rates in coastal regions compared to continental regions (81.3 and 71.0%, respectively). Settlement type (urban, suburban\/rural) was not associated with the MV seroprevalence. The results of the multivariable logistic regression analysis showed that year, age, and region were significantly associated with IgG seropositivity. Each additional calendar year was associated with lower odds of IgG positivity (OR = 0.82), while each additional year of age was associated with higher odds (OR = 1.04). Region was also a significant predictor (OR = 1.65), while settlement was not significantly associated with seropositivity after adjustment for other variables. Conclusions: Croatia has historically maintained high measles coverage, but lower uptake in some regions and age groups may be creating immunity gaps. The lower post-2022 seropositivity underscores significant immunity gaps, particularly among highly susceptible groups that were exposed to outbreaks and tested during that period.<\/jats:p>","DOI":"10.3390\/vaccines14050393","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:33:37Z","timestamp":1777376017000},"page":"393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Measles Immunity in the Croatian Population: A Retrospective Seroprevalence Study, 2015\u20132025"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1877-5547","authenticated-orcid":false,"given":"Tatjana","family":"Vilibi\u0107-\u010cavlek","sequence":"first","affiliation":[{"name":"WHO National Measles\/Rubella Laboratory, Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Barbi\u0107","sequence":"additional","affiliation":[{"name":"Statistic Concentrator, Harvard University, Cambridge, MA 02139, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8954-6846","authenticated-orcid":false,"given":"Vesna Vi\u0161ekruna","family":"Vu\u010dina","sequence":"additional","affiliation":[{"name":"Department of Communicable Disease Epidemiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Bogdani\u0107","sequence":"additional","affiliation":[{"name":"WHO National Measles\/Rubella Laboratory, Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Kai\u0107","sequence":"additional","affiliation":[{"name":"Department of Communicable Disease Epidemiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1099\/jgv.0.001328","article-title":"ICTV Report Consortium. ICTV Virus Taxonomy Profile: Paramyxoviridae","volume":"100","author":"Rima","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, February 28). Genetic Analysis of Measles Virus, Available online: https:\/\/www.cdc.gov\/measles\/php\/laboratories\/genetic-analysis.html."},{"key":"ref_3","unstructured":"World Health Organization (WHO) (2026, March 02). Measles. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/measles."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13062-025-00693-0","article-title":"Measles and public health: An integrative approach","volume":"20","author":"Branda","year":"2025","journal-title":"Biol. Direct"},{"key":"ref_5","unstructured":"Centers for Disease Control and Prevention (CDC) (2012). Progress in global measles control, 2000\u20132010. Morb. Mortal. Wkly. Rep., 61, 73\u201378."},{"key":"ref_6","unstructured":"Kondamudi, N.P., Tobin, E.H., and Waymack, J.R. (2026, February 28). Measles, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448068\/."},{"key":"ref_7","first-page":"959","article-title":"Subacute sclerosing panencephalitis\u2014The continuing threat","volume":"30","author":"Cavlek","year":"2006","journal-title":"Coll. Antropol."},{"key":"ref_8","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, March 01). Clinical Overview of Measles, Available online: https:\/\/www.cdc.gov\/measles\/hcp\/clinical-overview\/index.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.15585\/mmwr.mm7345a4","article-title":"Progress toward measles elimination\u2014Worldwide, 2000\u20132023","volume":"73","author":"Minta","year":"2024","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_10","unstructured":"World Health Organization (WHO) (2026, March 06). European Region Reports Highest Number of Measles Cases in More Than 25 Years\u2014UNICEF, WHO\/Europe. Available online: https:\/\/www.who.int\/europe\/news\/item\/13-03-2025-european-region-reports-highest-number-of-measles-cases-in-more-than-25-years---unicef--who-europe."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1026109201399","article-title":"Immunity to measles in Croatian population","volume":"18","year":"2003","journal-title":"Eur. J. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Szinger, D., Berki, T., Drenjan\u010devi\u0107, I., Samardzic, S., Zeli\u0107, M., Sikora, M., Po\u017egain, A., Markovics, \u00c1., Farkas, N., and N\u00e9meth, P. (2024). Raising epidemiological awareness: Assessment of measles\/MMR susceptibility in highly vaccinated clusters within the Hungarian and Croatian population\u2014A sero-surveillance analysis. Vaccines, 12.","DOI":"10.3390\/vaccines12050486"},{"key":"ref_13","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2026, March 05). Measles Annual Epidemiological Report for 2024. Available online: https:\/\/www.ecdc.europa.eu."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Drenjan\u010devi\u0107, I., Samard\u017ei\u0107, S., Stupin, A., Borocz, K., Nemeth, P., and Berki, T. (2022). Measles vaccination and outbreaks in Croatia from 2001 to 2019: A comparative study with other European countries. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19074140"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4161\/hv.25127","article-title":"Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and Bordetella pertussis in young adults of Madrid, Spain","volume":"9","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.lanepe.2021.100128","article-title":"Seroprevalence of measles-, mumps-, and rubella-specific antibodies in the German adult population\u2014Cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"7","author":"Friedrich","year":"2021","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nasika, A., Bogogiannidou, Z., Mouchtouri, V.A., Dadouli, K., Kyritsi, M.A., Vontas, A., Voulgaridi, I., Tsinaris, Z., Kola, K., and Matziri, A. (2023). Measles immunity status of the Greek population after the outbreak in 2017\u20132018: Results from a seroprevalence national survey. Vaccines, 11.","DOI":"10.20944\/preprints202306.1156.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"128039","DOI":"10.1016\/j.vaccine.2025.128039","article-title":"Seroprevalence of measles, mumps and rubella specific antibodies in the population of Slovakia: One vaccine, three different patterns","volume":"70","author":"Mikas","year":"2026","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2634496","DOI":"10.1080\/21645515.2026.2634496","article-title":"Immunity gap for measles in young adults: Seroprevalence study in blood donors in southern Italy","volume":"22","author":"Centrone","year":"2026","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126012","DOI":"10.1016\/j.vaccine.2024.05.060","article-title":"Seroprevalence of measles antibodies in the Italian general population in 2019\u20132020","volume":"42","author":"Grassi","year":"2024","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Popova, A.Y., Smirnov, V.S., Egorova, S.A., Draga\u010devi\u0107, L., Milichkina, A.M., Proti\u0107, J., Danilova, E.M., Drozd, I.V., Petru\u0161i\u0107, M., and Zhimbaeva, O.B. (2025). Herd immunity to the measles, mumps and rubella viruses among the Belgradian population in May 2024. Vaccines, 13.","DOI":"10.20944\/preprints202505.0344.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/eurpub\/ckac162","article-title":"Measles cases in Split-Dalmatia County (a Croatian tourist region), in May\u2013July 2019: Outbreak report and lessons learnt","volume":"32","author":"Brzovic","year":"2022","journal-title":"Eur. J. Public Health"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bianchi, S., Canuti, M., Ciceri, G., Gori, M., Colzani, D., Dura, M., Pennati, B.M., Baggieri, M., Magurano, F., and Tanzi, E. (2020). Molecular Epidemiology of B3 and D8 Measles Viruses Through Hemagglutinin Phylogenetic History. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124435"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:19:42Z","timestamp":1777378782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/5\/393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["vaccines14050393"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14050393","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}